ecrin-mdr-crcClinical2011Metastatic Colorectal CancerColorectal NeoplasmsMetastatic Colorectal CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2120337France7RaltitrexedOxaliplatinUnresectable metastasesBevacizumabECRIN MDRTerminatedfalse2nd-line Treatment of Metastatic Colorectal CancerThis phase 2 trial aims to evaluate the continued use of bevacizumab with raltitrexed and oxaliplatin combination versus FOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer whose disease has progressed after irinotecan-based chemotherapy.2011-07-152120337NCT015328042010-023447-15